Retinitis pigmentosa

• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pig … Not authorised
  2024-511181-36-00 5 "X-linked retinitis pigmentosa (XLRP)"
• A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with … Not authorised
  2024-515199-10-00 4 "Retinitis Pigmentosa"
• Safety of stem cells in treatmemt of retinal diseases. Pending
  2023-503573-38-00 3 "Retinal degenerative diseases"
• A Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retiniti … Recruiting
  2024-515199-10-01 4 2025-09-29 "Retinitis Pigmentosa"
• A trial in patients suffering from a specific form of an eye disorder called retinitis pigmentosa Recruiting
  2023-504383-42-00 7 2025-02-02 "Retinitis Pigmentosa (due to CNGA1 mutation)"
• A Long-term Follow-up Study to Evaluate the Safety and Efficacy of Retinal Gene Therapy in Subjects with Choroideremia Previously Treated wi … Recruiting
  2023-507994-16-00 5 2024-10-07 "Choroideremia (CHM) X-Linked Retinitis Pigmentosa (XLRP)"
• Tissue replacement in RPE related dystrophies Recruiting
  2024-513662-18-00 7 2019-08-19 "Patients with retinitis pigmentosa due to monogenic mutation"
• A Phase 1/2a gene therapy clinical trial in Retinitis Pigmentosa subjects. Recruiting
  2024-516059-42-00 9 2017-12-22 "Retinitis Pigmentosa"
• NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Or … Recruitment ended
  2022-501438-46-00 5 2024-01-22 "Retinitis Pigmentosa"
• Long Term Follow-Up study of Gene Therapy Trial for Patients with Retinitis Pigmentosa (progressive reduction in vision) due to a gene defec … Recruitment ended
  2024-511411-25-00 5 2022-08-25 "X-Linked Retinitis Pigmentosa caused by mutations in the RPG"
• Explore the safety and efficacy of subretinal administration of CPK850 gene therapy in patients with retinitis pigmentosa caused by mutation … Ended
  2023-508688-54-00 7 2018-08-22 "Retinitis pigmentosa caused by biallelic mutations in the RL"
• Safety and Efficacy of a Unilateral Subretinal Administration of HORA PDE6B in Patients with Retinitis Pigmentosa Harbouring Mutations in th … Ended
  2024-511687-90-00 7 2017-10-12 "retinitis pigmentosa"

Showing 1–12 of 12 trials